In clinical practice, physicians make a series of treatment decisions over the course of a patient's disease based on his/her baseline and evolving characteristics. A dynamic treatment regime is a set of sequential decision rules that operationalizes this process. Each rule corresponds to a key decision point and dictates the next treatment action among the options available as a function of accrued information on the patient. Using data from a clinical trial or observational study, a key goal is estimating the optimal regime, that, if followed by the patient population, would yield the most favorable outcome on average. Q-learning and advantage (A-)learning are two main approaches for this purpose. We provide a detailed account of Q-and A-learning and study systematically the performance of these methods.
Introduction
In the health sciences, an area of considerable current interest is personalized medicine, which involves making treatment decisions for an individual patient using all information available on the patient, including genetic, physiologic, demographic, and other clinical variables, to achieve the "best" outcome for the patient given this information. In treating a patient with an ongoing disease or disorder, a clinician makes a series of decisions based on the patient's evolving status, so seeking to tailor treatment to the patient. A dynamic treatment regime is a list of sequential decision rules that formalizes this process. Each rule corresponds to a key decision point in the disease or disorder progression and takes as input the information on the patient to that point and outputs the treatment that s/he should receive from among the available options. A key step toward personalized medicine is thus finding the optimal dynamic treatment regime, that which, if followed by the entire patient population, would yield the most favorable outcome on average.
The statistical problem is to estimate the optimal regime based on data from a clinical trial or observational study. Q-learning (Q denoting "quality, " Watkins, 1989; Watkins and Dayan, 1992; Nahum-Shani et al., 2010) and advantage learning (A-learning, Murphy, 2003; Blatt, Murphy, and Zhu, 2004) are two main approaches proposed for this purpose. Both follow from developments on reinforcement learning methods for sequential decision-making in the computer science literature. As described shortly, Q-learning is based roughly on posited regression models for the outcome of interest given patient information at each decision point and is implemented through a backwards (in time) recursive fitting procedure that is related to the dynamic programming algorithm (Bather, 2000) , a standard approach for deducing optimal sequential decisions. A-learning involves the same recursive strategy, but, instead of requiring full regression relationships to be posited, requires only models for the part of the outcome regression involved in representing contrasts among treatments along with models for the probability of observed treatment assignment given patient information at each decision point. As discussed in the sequel, this feature may make A-learning more robust to model misspecification than Q-learning for consistent estimation of the optimal treatment regime.
Examples of the use of Q-and A-learning and related methods to deduce optimal strategies for treatment of substance abuse, psychiatric disorders, cancer, and HIV infection and for dose adjustment in response to evolving patient status are given by (e.g., Rosthøj et al., 2006; Murphy et al., 2007a,b; Zhao, Kosorok, and Zeng, 2009; Henderson, Ansell, and Alshibani, 2010) . Related work includes Thall, Millikan, and Sung (2000) , Thall, Sung, and Etsey (2002) , Robins (2004) , Moodie, Richardson, and Stephens (2007) , Thall et al. (2007) , Robins, Orellana, and Rotnitzky (2008) , Almirall, Ten Have, and Murphy (2010) and Orellana, Rotnitzky, and Robins (2010) .
Despite increasing interest in estimation of optimal dynamic treatment regimes, there has been little study of the relative merits of Q-and A-learning, nor of consequences of misspecification of the postulated models involved. Moreover, although descriptions of Q-and A-learning are available, a self-contained account of both has not been presented. In this article, we provide a detailed description of an appropriate statistical framework in which an optimal regime may be defined formally and introduce Q-and A-learning in this context. Conditions under which these methods may be expected to yield credible estimators for optimal regimes based on observed data are discussed, and we report on a systematic study of the methods' performance.
Section 2 introduces the statistical framework, and Section 3 makes precise the form of an optimal regime. We describe and contrast Q-and A-learning in Section 4 and present extensive simulations evaluating their performance, including under model misspecification, in Section 5. The methods are demonstrated using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D, Rush et al., 2004) study in Section 6.
Framework and Assumptions
We consider the general setting of K prespecified, ordered decision points, indexed by k = 1, . . . , K, which may be times or events in the disease or disorder process that necessitate a treatment decision, where, at each point, a set of treatment options is available. Assume that there is a final outcome Y of interest for which, without loss of generality, large values are preferred. The outcome may be ascertained following the Kth decision, as in the case of CD4 T-cell count at a prespecified follow-up time in a study of HIV infection (Moodie et al., 2007) ; or may be a function of information accrued over the entire sequence of decisions, as in Henderson et al. (2010) , where outcome is the overall proportion of time a measure of blood clotting speed is kept within a target range in a study of dosing of anticoagulant agents.
In order to define an optimal treatment regime and discuss estimation of an optimal regime based on data from an observational study or clinical trial, we first define a suitable conceptual framework. For simplicity, our presentation is heuristic. We imagine that there is a superpopulation of patients, denoted
by Ω, where one may view an element ω ∈ Ω as a patient from this population. We assume that patients in the population have been treated and otherwise have behaved according to routine clinical practice for the disease or disorder prior to the first treatment decision. Consequently, immediately prior to this first decision, patient ω would present to the decision-maker with a set of baseline information (covariates) denoted by the random variable S 1 ; we discuss this further below. Thus, S 1 (ω) is the value of his/her information immediately prior to decision 1 under these conditions, taking values s 1 , say, in a set S 1 .
Assume that, at each decision point k = 1, . . . , K, there is a set of possible treatment options A k , where we denote elements of A k by a k . We writeā k = (a 1 , . . . , a k ) to denote a possible treatment history that could be administered through the kth decision, taking values in the corresponding setĀ k = A 1 × · · · × A k .
Thus,Ā K denotes the set of all possible full treatment historiesā K through all K decisions.
We then define the potential outcomes (Robins, 1986) W = {S that this definition includes the baseline covariate S 1 and is taken equal to S 1 when k = 1. In what follows, for simplicity, we take all random variables to be discrete, but the results we present hold more generally.
Let the random variables A (P ) 1 , . . . , A (P ) K denote the treatments that would be assigned to patients in the population at decisions 1, . . . , K under routine clinical practice, so that A (P ) k (ω) is the treatment in A k that patient ω would receive at decision k, taking values a k ∈ A k . By routine clinical practice, we mean the conditions under which patients in the population and their providers would make treatment decisions acting as they see fit, emphasized by the superscript (P ) (for "population"), to be distinguished from those of a clincial trial, discussed later. Thus, the A (P ) k characterize the mechanism by which treatments are assigned in the population if patients and clinicians are left to their own devices. Likewise, define the random variables S (P ) k , k = 2, . . . , K, to be the covariate information that would be observed on patients in the population between decisions k − 1 and k under the treatment assignments A (P ) k , taking values s k ∈ S k ; let Y (P ) be the corresponding observed outcome, taking values y in a set Y; and definē
1 , . . . , A
k ), taking valuesā k ∈Ā k . Henceforth, as is standard, we make the consistency assumption (e.g., Robins, 1994) that the covariates and outcomes that would be observed under these conditions are those that potentially would be seen under the treatments actually received; that is, for patient ω ∈ Ω, S (P ) k (ω) = S * k {Ā (P ) k−1 (ω)}(ω), k = 2, . . . , K, and Y (P ) (ω) = Y * {Ā (P ) K (ω)}(ω). We also make the stable unit treatment value assumption (Rubin, 1978) , which ensures that a patient's covariates and outcome are unaffected by how treatments are allocated to her/him and other patients.
Under this conceptualization, probabilities for events in Ω are induced by random sampling from this population, as are all probability distributions of the potential data above and observed data that would be obtained from studies carried out in the population. The goal of Q-and A-learning is to estimate the optimal treatment regime based on data from an observational study or clinical trial carried out in a random sample from this population.
is a set of rules that dictates an algorithm for treating a patient over time. At the kth decision point, the kth rule d k (s k ,ā k−1 ), say, takes as input the patient's realized covariate and treatment history prior to the kth treatment decision and outputs a value a k ∈ Ψ k (s k ,ā k−1 ) ⊆ A k ; for k = 1, there is no prior treatment (a 0 is null), and we write d 1 (s 1 ) and Ψ 1 (s 1 ).
Here, Ψ k (s k ,ā k−1 ) is the set of feasible treatment options for a patient with realized history (s k ,ā k−1 ), reflecting that some treatment options may be unethical or impossible for patients with certain histories.
We discuss considerations for identifying the Ψ k (s k ,ā k−1 ) shortly. Because we consider only regimes where
We define these subsets recursively as
for k = 1, . . . , K. Thus, we may define formally the class of all feasible treatment regimes D, say, as
Intuitively, an optimal regime should represent the "best" way to intervene to treat patients in Ω who would otherwise behave according to routine clinical practice. We now state with specificity what we mean by this. To this end, for any
represents the covariate information that would arise between decisions k −1 and k were patient ω to receive the treatments sequentially dictated by the first k −1 rules in
is the final outcome that ω would experience if s/he were to receive the K treatments dictated by d.
With these definitions, the expected outcome in the population if all patients with initial state S 1 = s 1 were to follow regime d is E{Y
In Section 3, we give the form of d opt satisfying (4) and demonstrate further optimality properties.
Of course, potential outcomes for a given patient for all d ∈ D are not observed. Thus, the goal is to estimate d opt in (4) using data from a study carried out on a random sample of n patients from Ω that record baseline and evolving covariate information and the treatments actually received by the participants. We denote the available study data as independent and identically distributed (i.i.d.) time-ordered random
. . , n on Ω. Here, S 1 is as before; S k , k = 2, . . . , K, is the covariate information recorded between decisions k − 1 and k, taking values
is the recorded, observed treatment assignment, taking values a k ∈ A k ; and Y is the observed outcome, taking values y ∈ Y. As above, we defineS
It is important to recognize that the nature of the study generating the available data must be considered carefully. If the data arise from an observational study in which covariate, treatment, and outcome information on n participants randomly sampled from Ω is recorded, with no intervention by investiga-tors, then it is reasonable to assume that the mechanism by which treatments are assigned to the patients in the sample during the study is the same as that for the entire population under routine practice. In
k , so that, under the consistency assumption, for k = 2, . . . , K,
Here, the form of
. . , K, is determined by treatment choices dictated by clinical practice.
Such a correspondence between the S k , A k and S
is not the case for an intervention study.
A clinical trial design that has been advocated for collecting data suitable for estimating optimal treatment regimes is that of a so-called sequential multiple-assignment randomized trial (SMART, Lavori and Dawson, 2000; Murphy, 2005) . In a SMART involving K pre-specified decision points, each participant is randomized at each decision point to one of a set of feasible treatment options, where, at the kth decision, the randomization probabilities may depend on past realized informations k ,ā k−1 . As we discuss further shortly, as with any clinical trial, an advantage is that the usual issues of confounding associated with an observational study are obviated. However, the treatment assignment mechanism in the study is no longer the same as that in the population under routine practice. More precisely, the sample space is now Ω ×Ā K , where for any element (ω ×ā K ), ω represents the patient randomly sampled from the population, andā K represents the treatments assigned to her/him at all K decisions by the random mechanism dictated by the trial design. Here, then, the observed
in general. Moreover, the treatment options in Ψ k (s k ,ā k−1 ) are dictated by the trial design so may be different from those in routine practice. In particular, the set of treatment options at each decision might be restricted relative to those available in clinical practice for reasons of logistics, cost, or interest of the trial sponsor in only certain products. We discuss further considerations for using data from a SMART to estimate optimal regimes in Section A.2 of the Appendix.
In order to use the observed data from either type of study to estimate an optimal regime, the critical assumption of no unmeasured confounders, also referred to as the sequential randomization assumption (Robins, 1994) , must be satisfied. A version of this assumption states that A k is conditionally independent terms of the observed data under assumptions including those of the last section. In the following, we sometimes highlight dependence on specific elements of quantities such asā k , writing, for example,ā k as
At the Kth decision point, for anys
For k = K −1, . . . , 1 and anys
so that, for s 1 ∈ S 1 , d
(1)opt 1
2 {s 1 , S * 2 (a 1 ), a 1 }|S 1 = s 1 ], and V
2 {s 1 , S * 2 (a 1 ), a 1 }|S 1 = s 1 ]. Note that the above conditional expectations are well-defined
(1)opt K ) defined above is a treatment regime, as it comprises a set of rules that uses patient information prior to each decision to assign treatment from among the feasible options. The superscript (1) indicates that d (1)opt provides a set of K rules for a patient presenting prior to decision point 1 with baseline information S 1 = s 1 . Note that d (1)opt is defined in a backward iterative fashion. At the Kth decision, (5) gives the treatment among the feasible options at decision K that maximizes the expected potential final outcome given the prior potential information available, and (6) is the maximum value achieved. At decisions k = K − 1, . . . , 1, intuitively, (7) gives the treatment that maximizes the expected outcome that would be achieved if subsequent optimal rules already defined were followed henceforth.
In Section A.1 of the Appendix, we provide a formal argument demonstrating that d (1)opt defined in (5)- (8) is an optimal treatment regime in the sense of satisfying (4). Note that, because (4) is true for any
Thus, from a policy perspective, d
(1)opt defines the optimal strategy for treating patients in the population through all K decisions were they to be encountered at the stage of the disease or disorder that precedes decision point 1.
In routine clinical practice, however, patients may be encountered at later stages. Consider a patient ω ∈ Ω for whom the first − 1 treatment decisions have been made as seen fit by her/him and her/his provider, = 2, . . . , K. Immediately prior to the th decision, the patient would have past historyS (P ) (ω) = s ,Ā
−1 (ω) =ā −1 , raising the issue of how best to intervene to treat such a patient henceforth, from the th to Kth decisions. That is, we desire rules d 
Then, by analogy to (4), we seek d ( )opt satisfying
−1 =ā −1 ) > 0. Viewing this as a problem of making K − + 1 decisions at decision points , + 1, . . . , K, with initial statē
−1 =ā −1 , by an argument analogous to that in Section A.1 of the Appendix for = 1 and initial state S 1 = s 1 , it may be shown that d ( )opt satisfying (9) is given by
Comparison of (5)- (8) to (10)- (13) shows that the th to Kth rules of the optimal regime d (1)opt that would be followed by a patient presenting at the first decision are not necessarily the same as those of the optimal regime d ( )opt that would be followed by a patient presenting at the th decision. In particular, noting that the conditioning sets in (5)-(8) are V 1,K and V 1,k , the rules are -dependent through dependence of the conditioning sets V ,k , = 1, . . . , K, k = , . . . , K, on . However, we demonstrate shortly that these rules coincide under certain conditions.
The foregoing developments define optimal regimes in terms of potential outcomes. To be useful in practice, an optimal regime must be defined in terms of the observed data. To this end, define
Note that all quantities in (14)- (19) are expressed entirely in terms of the distribution of the observed data.
In Section A.2 of the Appendix, under the consistency and sequential randomization (no unmeasured confounders) assumptions, along with positivity assumptions on probabilities associated with events in-
K given in Section A.2 of the Appendix, we show that
for (s k ,ā k−1 ) ∈ Γ k for = 1, . . . , K and k = , . . . , K. The equivalence in (20)- (22) not only demonstrates that an optimal treatment regime can be obtained using the distribution of the observed data but also that the corresponding rules dictating treatment do not depend on under these assumptions. Thus, (20)- (22) imply that the single set of rules (15) and (18) is relevant regardless of when a patient presents. That is, treatment at the th decision point for a patient who presents at decision 1 and has followed the rules in d opt to that point would be determined by d opt evaluated at his/her history up to that point, as would treatment for a subject presenting for the first time immediately prior to decision (14) and (17) are referred to as the "Q-functions," viewed as measuring the "quality" associated with using treatment a k at decision k given the history up to that decision and then following the optimal regime thereafter. The "value functions" V k (s k ,ā k−1 ) in (16) 4 Q-and A-Learning
Q-Learning
From (15) and (18), the optimal regime d opt is defined in terms of the Q-functions (14), (17). Thus,
. . , n, may be accomplished via direct modeling and fitting of the Q-functions. This is the approach underlying Q-learning. Specifically, one may posit models Q k (s k ,ā k ; ξ k ), say, for k = K, K − 1, . . . , 1, each depending on a finite-dimensional parameter ξ k . The models may be linear or nonlinear in ξ k and include main effects and interactions in the elements ofs k andā k .
Estimators ξ k may be obtained in a backward iterative fashion for k = K, K − 1, . . . , 1 by solving suitable estimating equations [e.g., ordinary (OLS) or weighted (WLS) least squares]. Assuming the latter,
in (15) and accordingly writing d
, substituting ξ K for ξ K yields an estimator for the optimal treatment choice at decision K for a patient with past historyS
To obtain ξ K−1 , setting k = K − 1, based on (17), one would then solve in ξ k
where
an estimator for the optimal treatment choice at decision K − 1 for a patient with past historyS
, assuming s/he will take the optimal treatment at decision K. One would continue this process in the obvious fashion for
and solving equations of form (24) to obtain ξ k and corresponding
We may now summarize the estimated optimal regime as d
It is important to recognize that the estimated regime (25) may not be a credible estimator for the true optimal regime unless all the models for the Q-functions are correctly specified.
We illustrate for the case K = 2, where at each decision there are two feasible treatment options coded as 0 and 1; i.e., Ψ 1 (s 1 ) = A 1 = {0, 1} for all s 1 and Ψ 2 (s 2 , a 1 ) = A 2 = {0, 1} for alls 2 and a 1 ∈ {0, 1}.
Let
As in many modeling contexts, it is standard to adopt linear models for the Q-functions; accordingly, consider the models
which is a standard regression problem involving observable data, whereas Q 1 (s 1 , a 1 ; ξ 1 ) is a model for the
A 1 = a 1 , which is an approximation to a complex relationship involving a maximization. Under (26), it is straightforward to deduce that V 2 (s 2 , a 1 ;
and
in (26) in (15) and (18) 
We have presented (23) and (24) in the conventional WLS form, with leading term in the summand
; taking Σ k to be a constant yields OLS. At the Kth decision, with responses Y i , standard theory implies that this is the optimal leading term when var(
, yielding the efficient (asymptotically) estimator for ξ K . For k < K, with "responses" V (k+1)i , this theory may no longer apply; however, deriving the optimal leading term involves considerable complication. Accordingly, it is standard to fit the posited models Q k (s k ,ā k ; ξ k ) via OLS or WLS; some authors define Q-learning as using OLS (Chakraborty, Murphy, and Strecher, 2010) . The choice may be dictated by apparent relevance of the homoscedasticity assumption on the
and whether or not linear models are sufficient to approximate the relationships may also be evaluated, but see Section 4.3.
A-Learning
Advantage learning (A-learning, Murphy, 2003) is an alternative to Q-learning that involves making fewer assumptions on the form of the Q-functions. For simplicity, we consider the case of two feasible treatment options coded as 0 and 1 at each decision; i.e., Ψ k (s k ,ā k−1 ) = A k = {0, 1}, k = 1, . . . , K, though the methodology can be extended to an arbitrary number of treatments at each stage at the expense of complicating the formulation and notation.
To fix ideas, consider (26). Note that
. This is a special case of the general result that, for purposes of deducing the optimal regime, for each k = 1, . . . , K, it suffices to know the contrast function
and the maximum itself is the expression
The premise of A-learning is thus to model the contrast functions rather than the full Q-functions as in Q-learning. For k = K − 1, . . . , 1 the latter involve possibly complex relationships, raising concern over the consequences of model misspecification for estimation of the optimal regime. As identifying the optimal regime depends only on correct specification of the contrast functions, A-learning may be less sensitive to mismodeling.
We now describe the A-learning procedure. Assume posited models
say, for the contrast functions, each depending on a parameter ψ k . Consider the Kth decision. Given
) be the propensity of receiving treatment 1 in the observed data as a function of past history and writing Robins (2004) showed that all consistent and asymptotically normal estimators for ψ K are solutions to estimating equations of the form
otherwise, the optimal λ K is complex (Robins, 2004) .
To implement estimation of ψ K via (27), one may adopt parametric models for these functions. Although the appeal of A-learning is that it obviates the need to specify fully the Q-functions, one may posit
Moreover, unless the data are from a SMART study, in which case the propensities π K (s K ,ā K−1 ) would be known, these may also be modeled as
(e.g., by a logistic regression). These models are only adjuncts to estimating the parameter of interest, ψ K ; interestingly, as long as at least one of these models is correctly specified, (27) will yield a consistent estimator for ψ K , the so-called double robustness property. Substituting these models in (27), one solves
and the usual binary regression likelihood score equations in φ K . We then have d
; as in Q-learning, substituting ψ K yields an estimator for the optimal treatment choice at decision K for a patient with past historyS
With ψ K in hand, as with Q-learning, the A-learning algorithm proceeds in a backward iterative fashion
) a system of estimating equations analogous to those above. As in Q-learning, the kth set of equations is based on "responses"
is referred to as the advantage or regret function (Murphy, 2003) , as it represents the "advantage" in response incurred if the optimal treatment at the kth decision were given relative to that actually received (or, equivalently, the "regret" incurred by not using the optimal treatment). Accordingly, define recursively
for a given specification λ k (s k ,ā k−1 ; ψ k ), solved jointly with the maximum likelihood score equations for
. As above, the optimal λ k is complex Robins (2004) 
Summarizing, the estimated optimal regime d
As with Q-learning, how well d 
Comparison and Practical Considerations
When K = 1, the Q-function is a model for E(Y |S 1 = s 1 , A 1 = a 1 ). If in Q-learning this model and the variance model Σ 1 in (23) are correctly specified, then, as noted above, the form of (23) is optimal for estimating ξ 1 . Accordingly, even if C 1 (s 1 ; ψ 1 ) and h 1 (s 1 ; β 1 ) are correctly modeled, (28) with K = 1 is generally not of this optimal form for any choice λ 1 (s 1 ; ψ 1 ), and hence A-learning will yield relatively inefficient inference on ψ 1 and hence on the optimal regime. However, if in Q-learning the Q-function is mismodeled, but in A-learning C 1 (s 1 ; ψ 1 ) and π 1 (s 1 ; φ 1 ) are both correctly specified, then A-learning will still yield consistent inference on ψ 1 and hence the optimal regime, whereas inference on ξ 1 and the optimal regime via Q-learning may be inconsistent. We assess the trade-off between consistency and efficiency in this case in Section 5. For K > 1, owing to the complications involved in specifying optimal estimating equations for Q-and A-learning, the relative performance of the methods is not readily apparent; we investigate in Section 5.
In certain special cases, Q-and A-learning lead to identical estimators for the Q-function (Chakraborty et al., 2010) . For example, this holds if the propensities for treatment are constant, as would be the case under pure randomization at each decision point, and certain linear models are used for C 1 (s 1 ; ψ 1 ) and h 1 (s 1 ; β 1 ); see Section A.4 of the Appendix for a demonstration when K = 1 and pr(A 1 = 1|S 1 = s 1 ) does not depend on s 1 .
As we have emphasized, for Q-learning, while modeling the Q-function at decision K is a standard regression problem with response Y , for decisions K − 1, . . . , 1, this involves modeling the estimated value function, which depends on the relationships for subsequent decisions. Ideally, the sequence of posited models Q k (s k ,ā k ; ξ k ) should respect this constraint. However, this may be difficult to achieve with standard regression models. To illustrate, consider the models in (26), and assume S 1 , S 2 are scalar, where the 
Letting ϕ(·) and Φ(·) be the standard normal density and cumulative distribution function, respectively, it may be shown (see Section A.5 of the Appendix) that, under these conditions,
/σ, and we have taken ψ 22 > 0. Contrast the implied true Q 1 (s 1 , a 1 ) in (30) to the posited linear model in (26); clearly, the true relationship is highly nonlinear in s 1 , a 1 and is likely to be poorly approximated by Q 1 (s 1 , a 1 ; ξ 1 ) in (26). Evidently, for larger K, this incompatibility between true and assumed models would propagate from K − 1, . . . , 1. Thus, while the use of linear models for the Q-functions is popular in practice, the potential for such mismodeling should be recognized.
An alternative approach that may mitigate the risk of mismodeling is to employ flexible models for the Q-functions. Zhao, Kosorok, and Zeng (2009) use support vector regression models in place of the linear models described above. Indeed, recent developments in statistical learning suggest a large collection of powerful regression methods that might be used. Many of these methods must be tuned in order to balance bias and variance, a natural approach to which is to minimize the cross-validated mean squared error of the Q-functions at each decision point. An obvious downside is that the final model may be difficult to interpret, and clinicians may be unwilling to implement "black box" rules. Craven and Shavlik (1996) .
A-learning represents a middle ground between Q-learning and these approaches in that it allows for flexible modeling of the functions h k (s k ,ā k−1 ) while maintaining simple parametric models for the contrast functions C k (s k ,ā k−1 ). Thus, the resulting decision rule, which depends only on the contrast function, remains interpretable, while the model for the response is allowed to be nonlinear. This is also appealing in that it may be reasonable to expect, based on the underlying science, that the relationship between patient history and outcome is complex while the optimal rule for treatment assignment is dependent, in a simple fashion, on a small number of variables. The flexibility allowed by a semi-parametric model also has its drawbacks. Techniques for formal model building, critique, and diagnosis are well understood for linear models but much less so for semi-parametric models. Consequently, Q-learning based on building a series of linear models may be more appealing to an analyst interested in formal diagnostics.
Simulation Studies
We examine the finite sample performance of Q-and A-learning on a suite of test examples via Monte Carlo simulation. To illustrate the trade-offs between the methods discussed in the preceding sections, we begin with correctly specified models and then systematically introduce misspecification of the Q-function, the propensity model, and both the Q-function and propensity model. In all cases, the contrast function is correctly specified, as, when this is not the case, the form of the optimal regime induced by an incorrect contrast function may not include d opt , making interpretation difficult. In all scenarios, 10,000 Monte Carlo replications were used, and, for each generated data set, the estimated optimal regimes d (25) and (29) were obtained using the Q-and A-learning procedures described in Sections 4.1 and 4.2.
For simplicity, we consider one (K = 1) and two stage (K = 2) decision problems, where, at each decision point, there are two feasible treatment options coded as 0 and 1. In all cases, we used Q-functions
to represent both true and assumed working models. With the contrast functions correctly specified, the parameters ψ k , k = 1, 2, dictate the optimal regime. Thus, as one measure of performance, we focus on relative efficiency of the estimators of components of ψ k obtained by Q-learning to those obtained by 
, where the expectation in the numerator is with respect to the distribution of the estimated parameters in d opt , which may be interpreted as reflecting the efficiency with which d opt achieves the performance of the true optimal regime. In Section A.6 of the Appendix, we discuss calculation of R( d opt ).
One Decision Point
In this and the next section, n = 200. Here, the observed data are (S 1i , A 1i , Y i ), i = 1, . . . , n. With expit(x) = e x /(1 + e x ), to generate the data, we used . For A-learning, we assumed working models h 1 (s 1 ; β 1 ) = β 10 + β 11 s 1 , C 1 (s 1 ; ψ 1 ) = ψ 10 + ψ 11 s 1 , and π 1 (s 1 ; φ 1 ) = expit(φ 10 + φ 11 s 1 ), and for Q-learning used Q 1 (s 1 , a 1 ; ξ 1 ) = h 1 (s 1 ; β 1 ) + a 1 C 1 (s 1 ; ψ 1 ). Note that these working models involve correctly specified contrast functions and are nested within the true generative models, with h 1 (s 1 ; β 1 ), and hence the Q-function, correctly specified when β 0 12 = 0. Similarly, the propensity model π 1 (s 1 ; φ 1 ) is correctly specified when φ Correctly specified models. As noted in Section 4.3, when all working models are correctly specified, Q-learning is more efficient than A-learning. Under our class of generative models, this occurs when As in the preceding scenario, Figure 3 illustrates the bias-variance trade-off associated with Q-and A-learning. For large misspecification, A-learning provides a large enough reduction in bias to yield lower MSE; for small misspecification, Q-learning incurs some bias but reduces the variance enough to yield lower MSE. From the right panel of the figure, bias seems to translate into a larger loss in quality of the estimators of d opt than variance.

Two Decision Points
For K = 2, the observed data available to estimate
For these scenarios, we used a class of true generative data models that differs from those of Chakraborty We assumed working models for A-learning of the form h 1 (s 1 ; β 1 ) = β 10 + β 11 s 1 , C 1 (s 1 ; ψ 1 ) = ψ 10 + ψ 11 s 1 , π 1 (s 1 ; φ 1 ) = expit(φ 10 +φ 11 s 1 ), h 2 (s 1 , s 2 , a 1 ; β 2 ) = β 20 +β 21 s 1 +β 22 a 1 +β 23 s 1 a 1 +β 24 s 2 , C 2 (s 1 , s 2 , a 1 ; ψ 2 ) = ψ 20 + ψ 21 a 1 + ψ 22 s 2 , and π 2 (s 1 , s 2 , a 1 ; φ 2 ) = expit(φ 20 + φ 21 s 1 + φ 22 a 1 + φ 23 s 2 + φ 24 a 1 s 2 ); and, similarly, assumed Q-functions of the form Q 1 (s 1 , a 1 ; ξ 1 ) = h 1 (s 1 ; β 1 ) + a 1 C 1 (s 1 ; ψ 1 ) and Q 2 (s 1 , s 2 , a 1 , a 2 ; ξ 2 ) = h 2 (s 1 , s 2 , a 1 ; β 2 ) + a 2 C 2 (s 1 , s 2 , a 1 ; ψ 2 ) for Q-learning, so that the contrast functions are correctly specified in each case. Comparison of the working and generative models shows that the former are correctly specified when φ Correctly specified models. Given our working models, this occurs when φ ψ 20ψ 21ψ 22ψ 10ψ 20ψ 21ψ 22ψ 10that are "equivalently misspecified;" see Section A.7 of the Appendix. Figure 6 shows the relative efficiency of the two methods. There is no general trend in efficiency of estimation across parameters that might recommend one method over the other. Furthermore, from the lower right panel, there is little difference in efficiency of the estimated regimes. This is as expected, as one should not expect to draw broad conclusions, as neither Q-nor A-learning need be consistent here. Interestingly, despite misspecification of both models, 
Moodie and Richardson Scenario
The foregoing simulation scenarios deliberately involve simple models for the Q-functions in order to allow straightforward interpretation. To investigate the relative performance of the methods in a more challenging setting, we generated data from a scenario similar to that in Moodie et al. (2007) in which the true contrast functions are simple yet the Q-functions are complex.
The data generating process used mimics a study in which HIV-infected patients are randomized to receive antiretroviral therapy (coded as 1) or not (coded as 0) at baseline and again at six months, where the randomization probabilities depend on baseline and six month CD4 counts. Specifically, we generated baseline CD4 count S 1 ∼ Normal (450, 150 2 ), and baseline treatment A 1 was then assigned according
We generated six month CD4 count S 2 , distributed conditional on S 1 = s 1 , A 1 = a 1 as Normal(1.25s 1 , 60 2 ). Treatment A 2 was then generated according to 
It follows that the optimal treatment regime d opt = (d Following Moodie et al. (2007) , for A-learning, we assumed working models h 1 (s 1 ; β 1 ) = β 10 + β 11 s 1 , C 1 (s 1 ; ψ 1 ) = ψ 10 + ψ 11 s 1 , h 2 (s 1 , s 2 , a 1 ; β 2 ) = β 20 + β 21 s 1 + β 22 a 1 + β 23 s 1 a 1 + β 24 s 2 , and C 2 (s 1 , s 2 , a 1 ; ψ 2 ) = ψ 20 + ψ 21 s 2 , and assumed propensity models of the form π 1 (s 1 ; φ 1 ) = φ 10 + φ 11 s 1 and π 2 (s 1 , s 2 , a 1 ; φ 2 ) = φ 20 + φ 21 s 2 . For Q-learning, we analogously assumed Q-functions Q 1 (s 1 , a 1 ; ξ 1 ) = h 1 (s 1 ; β 1 ) + a 1 C 1 (s 1 ; ψ 1 ) and Q 2 (s 1 , s 2 , a 1 , a 2 ; ξ 2 ) = h 2 (s 1 , s 1 , a 1 ; β 2 ) + a 2 C 2 (s 1 , s 2 , a 1 ; ψ 2 ). Note that the contrast functions in each case are correctly specified, as are the propensity models; however, the Q-functions are misspecified, as the linear models h 1 (s 1 ; β 1 ) and h 2 (s 1 , s 1 , a 1 ; β 2 ) are poor approximations to the complex forms of the true h 0 1 (s 1 ) and h 0 2 (s 1 , s 2 , a 1 ).
We report results for n = 1000 with φ Under the assumed models, the estimated optimal regime for Q-learning dictates that, at baseline, antiretroviral therapy be given to patients with baseline CD4 count less than 199.7, while that estimated using A-learning gives treatment to those with baseline CD4 count less than 249.1, almost perfectly achieving the true optimal CD4 threshold of 250.
Under the data generative process, using the baseline decision rule estimated via Q-learning may result in as many as 4.4% of patients who would receive therapy at baseline under the true optimal regime being assigned no treatment. Similarly, at the second decision, the estimated optimal regimes obtained by Qand A-learning dictate that therapy be given to patients with six month CD4 count less than 320.2 and 360.1, respectively. Again, A-learning yields an estimated threshold almost identical to the optimal value of 360. Although that obtained via Q-learning is lower, 4.3% of patients who should receive therapy at six months would not if the estimated six month rule from Q-learning were followed by the population.
Using the approach outlined in Section A.6 of the Appendix, we have H(d opt ) = 1120, whereas E{H( d To demonstrate formulation of this problem within the framework of Sections 2 and 3, we take level 2A to be part of level 2 and consider only levels 2 and 3 of the study, calling them stages (decision points) 1 and 2, respectively (K = 2). Hence, we include in the analysis only the 1260 patients who entered level 2; 330 of these subsequently continued to level 3. Let A k , k = 1, 2, be the treatment assigned at stage k (beginning of level k + 1), taking values 0 (augment) or 1 (switch); both options are feasible for all eligible subjects. Let S 10 denote baseline QIDS score and S 11 denote the most recent QIDS score at level 1/beginning of level 2, respectively, so that S 1 = (S 10 , S 11 ) T is information available immediately prior to the first decision. Similarly, let S 2 be the information available immediately prior to decision 2; here, S 2 is the most recent QIDS score at the end of level 2/beginning of level 3. Finally, let T be QIDS score at the end of level 3. Because some patients exhibited adequate response at the end of level 2 and did not progress to level 3, we define the outcome of interest to be −S 2 (negative QIDS score at the end of level 2) for patients not moving to level 3 and −(S 2 + T )/2 (average of negative QIDS scores at the end of levels 2 and 3) otherwise. Thus, writing
cumulative average negative QIDS score. Thus, this demonstrates the case where outcome is a function of accrued information over the sequence of decisions.
It is straightforward to deduce from (14) that
Thus, from (17),
We describe implementation for Q-learning. At the second decision point, we must posit a model for Q 2 (s 2 ,ā 2 ). From the form of Q 2 (s 2 ,ā 2 ), we need only specify a model for E(−T |S 2 =s 2 ,Ā 2 =ā 2 , S 2 > l 0 );
given the form of the conditioning set, this may be carried out using only the data from patients moving to level 3. Based on exploratory analysis, defining s 22 to be the slope of QIDS score over level 2 based on s 11
and s 2 , we took this model to be of the form β 20 + β 21 s 2 + β 22 s 22 + ψ 20 a 2 , so that the posited Q-function
, and the "responses" V 2,i for use in (24) may then be formed by substituting the estimate for ξ 2 . Based on exploratory analysis, we took the posited Q-function at the first stage to be Q 1 (s 1 , a 1 ; ξ 1 ) = β 10 + β 11 s 11 + β 12 s 12 + a 1 (ψ 10 + ψ 11 s 12 ), where s 12 is the slope of QIDS score over level 1 based on s 10 and s 11 ; and ξ 1 = (β 10 , β 11 , β 12 , ψ 10 , ψ 11 ) T . For A-learning, we posited models for the functions h k (s k ,ā k−1 ) and C k (s k ,ā k−1 ), k = 1, 2, in the obvious way analogous to the models above, and we took the propensity models to be of the form π 2 (s 2 , a 1 ; φ 2 ) = expit(φ 20 + φ 21 s 2 + φ 22 s 22 + φ 23 a 1 ) and π 1 (s 1 ; φ 1 ) = expit(φ 10 + φ 11 s 11 + φ 12 s 12 ).
The results are presented in Table 2 . At the first stage, Q-learning suggests a treatment switch for those with level 1 QIDS slope greater than -0.97 (obtained by solving 1.12 + 1.15S 12 = 0); A-learning assigns a treatment switch for those with QIDS slope during level 1 greater than -1.07. At the second stage (level 3), the results suggest that all patients should switch treatment and not augment their existing treatments.
Discussion
We have provided a self-contained account of Q-and A-learning methods for estimating optimal dynamic treatment regimes, including a detailed discussion of the underlying statistical framework in which these methods may be formalized and of their relative merits. Our simulation studies confirm that, while Alearning may be inefficient relative to Q-learning in estimating parameters that define the optimal regime when the Q-functions required for the latter are correctly specified, A-learning may offer robustness to such misspecification. Nonetheless, Q-learning may have practical advantages in that it involves modeling tasks familiar to most data analysts, allowing the use of standard diagnostic tools. On the other hand, A-learning may be preferred in settings where it is expected that the form of the decision rules defining the optimal regime is not overly complex. However, A-learning increases in complexity with more than two treatment options at each stage, which may limit its appeal. Interestingly, our simulations demonstrate that inefficiency and bias in estimation of parameters defining the optimal regime does not necessarily translate into degradation of performance of the estimated regime for either method.
There remain many unresolved issues in estimation of optimal treatment regimes using these and other methods. Approaches to address the challenges of high-dimensional information and large numbers of decision points are required. Existing methods for model selection focusing on minimization of prediction error may not be best for developing models optimal for decision-making. Formal inference procedures for evaluating the uncertainty associated with estimation of the optimal regime are challenging due to the nonsmooth nature of decision rules, which in turn leads to nonregularity of the parameter estimators; see Chakraborty et al. (2010) , Laber et al. (2010) , Song et al. (2010) , and Laber and Murphy (2011) .
We have discussed sequential decision-making in the context of personalized medicine, but many other applications of these methods exist where, at one or more times in an evolving process, an action must be taken from among a set of plausible actions. Indeed, Q-learning was originally proposed in the computer science literature with these more general problems in mind; see Shortreed et al. (2010) for discussion. A.4) respectively. By the definition of d 
The equality in (A.5) holds for anyd
(1)opt
Thus, we also have that
Using (A.5) and (A.7) with k = K − 1, we thus have
Because of (A.6), the term in (A.8) is equal to E{Y
Again, becaused K−2 is arbitrary, if we replace it by (d K−3 , d
(1)opt K−2 ), the equality in (A.9) implies
(1)opt A.10) where, for any d,
. Using (A.7) with k = K − 2, (A.9), and (A.10), we obtain
Continuing in this fashion, we may conclude that, for any d ∈ D,
showing that d (1)opt defined in (5) and (7) is an optimal regime satisfying (4).
A.2 Demonstration of Correspondence in (20)-(22) Under Assumptions in Section 2
We first consider the case = 1. We make the positivity assumption that, for any (s k ,ā k−1 ) for which
This ensures that the observed data contain information on the treatments involved in the class of feasible regimes under consideration. We have Γ
(1) k = Γ k by definition, so we need only demonstrate (21) and (22). We must show that, for any ( (A.13) for j = 1, . . . , k, where we define (A.13) with j = k to be the same as the expression on the right-hand side of (A.12) and take S k+1 = Y and S *
Assume for the moment that (A.11) is true. We now demonstrate (A.12) and (A.13). For any fixed k, by the consistency assumption, the left-hand expression in (A.12) is equal to pr{S *
It follows by the sequential randomization assumption, which implies
, that this is equal to the right-hand side of (A.12). The equality in (A.13) follows by induction. Specifically, treating the right-hand side of (A.12) as (A.13) with j = k, the equality follows if we can show that (A.13) being true for a given j implies that it is also true for j − 1. For a given j = 2, . . . , k, by the consistency assumption, (A.13) is equal to pr{S *
which is (A.13) for j − 1. Note, then, that this implies that the conditional densities in (A.13), which are j-dependent, are the same as those on the left-hand side of (A.12), which are not.
We now prove (A.11) by induction. Assume we have shown that pr(
(A.14)
But we have shown above that if (A.11) is true; i.e., pr(S k =s k ,Ā k =ā k ) > 0, then (A.12) and (A.13) are equal for all j and in particular pr( .14) . Now pr(S k+1 =s k+1 ,Ā k+1 =ā k+1 ) = pr(A k+1 = a k+1 |S k+1 =s k+1 ,Ā k = a k )pr(S k+1 =s k+1 ,Ā k =ā k ); however, because a k+1 ∈ Ψ k (s k+1 ,ā k ) and by the positivity assumption, pr(A k+1 = a k+1 |S k+1 =s k+1 ,Ā k =ā k ) > 0 and hence pr(S k+1 =s k+1 ,Ā k+1 =ā k+1 ) > 0. The proof is complete by noting that pr(S 1 = s 1 , A 1 = a 1 ) = pr(A 1 = a 1 |S 1 = s 1 )pr(S 1 = s 1 ), where
by the positivity assumption.
To demonstrate (21) and (22) for = 1, consider first the definitions of d
given in (5) and (6). These quantities involve the conditional expectation of the potential outcome
, which by (A.12)-(A.13) is the same as the conditional expectation of Y given (15) and (16). Next, from (7) and (8), d
Again, by (A.12)-(A.13), this is the same as the conditional expectation of the function V
(1)
Because we have already shown that V
K is the same as V K , this implies that d
which is the same as d
given by (18) with k = K − 1. The argument continues in a backward iterative fashion for k = K − 2, . . . , 1.
Now consider > 1. The sets V ,k , = 1, . . . , K, k = , . . . , K, representing events of the form (10)- (13), depend on the random variablesS
k−1 for k = , . . . , K, which characterize how treatment assignment and covariate history arise in the population under routine practice. To demonstrate (20)- (22), in addition to those on the observed random variables given above, we also require sequential randomization and positivity assumptions on the "population" random variables; namely, that A
. . , K; and, for any (s k ,ā k−1 ) for which pr(S
If the observed data are from an observational study where S k , A k are the same as S
k , these assumptions are equivalent to those on the observed data. For data from a SMART, however, more consideration is required. If the treatment options considered in the trial are restricted relative to those available in practice, then an estimated optimal regime based on the observed data may not be applicable to patients who present at the th decision with treatment histories involving options not considered in the trial for > 1. The positivity assumption here rules out such patients from consideration. The sequential randomization assumption holds for observed data by design for a SMART. However, whether or not it holds in the population, as we require here, depends on whether or not the covariate information collected in the trial contains the information used by patients and their providers to make treatment decisions in routine practice. If this is not the case, then the estimated optimal regime based on the trial data is still applicable to patients who present prior to the first decision, = 1, but may not lead to optimal decision-making for patients presenting at subsequent decision points because the sequential randomization assumption at the population level may no longer hold.
Under these assumptions, it follows by an argument analogous to that above that (A.11)-(A.13) hold with the random variables S k , A k replaced by S .17) for j = 1, . . . , k. We may then show that (20) 
holds, then (A.15) holds. Because the set {S Now (21) and (22) follow by an argument similar to that for = 1. First, we argue that, for any fixed k = 1, . . . , K, the probabilities in (A.12) and (A.13) are the same as those in (A.16) and (A.17) for all j = 1, . . . , k. This follows because (A.13) with j = 1 is equal to (A.17) with j = 1. We may now use this to show the result. Consider the definitions of d (10) and (11). These quantities involve the conditional expectation of the potential outcome Y * (ā K ) given {S (P ) =s ,Ā (15) and (16), and this is true for all = 2, . . . , K. Next, in accordance with (21) and (22)
. Note that this involves the conditional expectation of the function V ( )
Again, this is the same as the conditional expectation of the function V ( )
K is independent of and equal to V K , this implies that
given by (18) with k = K − 1. The argument continues in an backward iterative fashion for k = K − 2, . . . , 1.
A.3 Justification for V ki in A-learning
We wish to show that
The inner expectation in (A.19) may be seen to be equal to A.4 Demonstration of Equivalence of Q-and A-learning in a Special Case
We take K = 1 and let pr(A 1 = 1|S 1 = s 1 ) = π. Consider the A-learning estimating equations (28) with k = 1, and take λ 1 (s 1 ; ψ 1 ) = ∂/∂ψ 1 C 1 (s 1 ; ψ 1 ). Then the equations become
Likewise, under these conditions, taking
where, with
Thus note that, with C 1 (s 1 ; ψ 1 ) and h 1 (s 1 ; β 1 ) linear in functions of S 1 , as long as terms of the form in C 1 (s 1 ; ψ 1 ) are contained in those in h 1 (s 1 , β 1 ), the Q-and A-learning estimating equations are identical, as then
For example, if C 1 (s 1 ; ψ 1 ) = ψ 10 + s T 1 ψ 11 and h 1 (s 1 ; β 1 ) = β 10 + s T 1 β 11 , then note that
and the result is immediate.
A.5 Example of Incompatibility of Q-function Models
To show (30), noting H 2 = (1, s 1 , a 1 , s 2 ) T = (K is straightforward to deduce that E{I(ψ 10 + ψ 11 S 1 > 0)} = pr(S 1 > −ψ 10 /ψ 11 ) or pr(S 1 < −ψ 10 /ψ 11 ) as ψ 11 > 0 or ψ 11 < 0, which is readily obtained from the standard normal cdf. Likewise, E{S 1 I(ψ 10 +ψ 11 S 1 > 0)} = E(S 1 |S 1 > −ψ 10 /ψ 11 )pr(S 1 > −ψ 10 /ψ 11 ) if ψ 11 > 0 and E{S 1 I(ψ 10 + ψ 11 S 1 > 0)} = E(S 1 |S 1 < −ψ 10 /ψ 11 )pr(S 1 < −ψ 10 /ψ 11 ) if ψ 11 < 0, which are again easily calculated in a manner similar to that in Section A.5. Thus, E{Y * (d opt )} is obtained by substituting ψ ) then yields the result that the corresponding t-statistics will be approximately equal. These were re-checked in the course of running the simulations so that the t-statistics differed by less than some reasonable value, usually at most a 5 percent difference, as it cannot be guaranteed that they will be precisely the same.
A.8 Derivation of h 
